CSIR- OSDD with Vigyan Prasar is conducting a YouTube based short video competition on "The Need of New Drugs for Tuberculosis". All individuals, including students above 18 years of age, educational institutions and organizations are invited to participate in the contest, and win attractive prizes !!!
Introduction
Vigyan Prasar in collaboration with Open Source Drug Discovery (OSDD) is organising a Short Video Competition on “The Need of New Drugs for TB” for which prizes will be awarded during the Indian Science Congress 2013. It is open to all producers, both private and government; individuals as well as production agencies and organisations. Media centres, television channels and media schools are also encouraged to participate. The participants are requested to upload their videos on YouTube and inform the URL through the form which is required to be submitted
The contest is open to all above 18 years of age (In India)
Objective
TB is a curable infection that affects more than 2 billion people across the globe annually, claiming almost 1.4 million lives. It is estimated that TB claims one life every 20 seconds around the globe. In India alone, over 1000 lives succumb to TB everyday (2 deaths every 3 minutes). Existing TB treatment makes use of combinatorial therapy involving 4 medicines (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide) and is administered for a period of 6 to 9 months under the direct observation of a physician (DOTS). These drugs were discovered in the middle of 20th century. The treatment regimen is too long and risk prone and the inadequate administration of existing treatment has resulted in the emergence of MDR (multiple drug resistant) TB and XDR (extremely drug resistant) TB. The emergence of drug resistant cases of TB, and lack of any new drugs since past 60 years, demands the discovery of more effective, novel drugs.
Short Video Competition on Tuberculosis is organised to create awareness.
See All B.Pharm Alerts Ph.D Alerts M.Pharm Alerts Pune Alerts
See All Other Jobs in our Database
